753
Views
151
CrossRef citations to date
0
Altmetric
Original

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

, , , , , , , , , & show all
Pages 233-241 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Takahisa Gono & Masataka Kuwana. (2023) New paradigm in the treatment of myositis-associated interstitial lung disease. Expert Review of Respiratory Medicine 17:5, pages 397-411.
Read now
Han Zhang, Xiang-Lei Yang & Litao Sun. (2021) The uniqueness of AlaRS and its human disease connections. RNA Biology 18:11, pages 1501-1511.
Read now
Masato Yoshikawa, Yoshinao Muro, Mariko Ogawa-Momohara, Satoru Ito, Takuya Takeichi & Masashi Akiyama. (2021) A case with overlapping features of IgG4-related autoimmune pancreatitis, Sjögren’s syndrome and anti-aminoacyl-tRNA synthetase syndrome. Modern Rheumatology Case Reports 5:1, pages 82-86.
Read now
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2019) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Modern Rheumatology 29:1, pages 1-19.
Read now
Ran Nakashima. (2018) Clinical significance of myositis-specific autoantibodies. Immunological Medicine 41:3, pages 103-112.
Read now
Takashi Ozaki, Hiroyuki Yamashita, Yuji Hosono, Ran Nakashima, Tsuneyo Mimori, Yuko Takahashi, Hiroshi Kaneko, Toshikazu Kano & Akio Mimori. (2014) Two patients in the same family with anti-ARS antibody-associated myositis. Modern Rheumatology 24:4, pages 699-700.
Read now
Yoshinao Muro, Kazumitsu Sugiura & Masashi Akiyama. (2013) Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 46:4, pages 279-284.
Read now
Sang Gyu Park, Ho Seon Park, In-Kyong Jeong, Young Min Cho, Hong Kyu Lee, Young-Sun Kang, Sunghoon Kim & Kyong Soo Park. (2010) Autoantibodies against aminoacyl-tRNA synthetase: novel diagnostic marker for type 1 diabetes mellitus. Biomarkers 15:4, pages 358-366.
Read now
S Nagai, T Handa & DS Kim. (2008) Pharmacotherapy in patients with idiopathic pulmonary fibrosis. Expert Opinion on Pharmacotherapy 9:11, pages 1909-1925.
Read now
Chiara Briani, Andrea Doria, Susanna Ruggero, Elisabetta Toffanin, Milena Luca, Maria paola Albergoni, Anna D'Odorico, Francesca Grassivaro, Marta Lucchetta, Franca De Lazzari, Italo Balzani, Leontino Battistin & Steven Vernino. (2008) Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. Autoimmunity 41:1, pages 100-104.
Read now

Articles from other publishers (139)

Archana Gudipati, Shaikh Rifat, Megha Uppin, Afshan Jabeen, Niharika L. Mathukumalli, Sireesha Yareeda, Sunitha Kayidhi, Anjan Pyal, Megha Dhamne & Y Muralidhar Reddy. (2023) Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience. Annals of Indian Academy of Neurology.
Crossref
Maki Ozaki, Tomoo Mano, Naoki Iwasa, Yoshifumi Yamamoto, Tsunenori Takatani, Akira Kido & Kazuma Sugie. (2023) Presymptomatic myositis in patients with antisynthetase syndrome associated with interstitial lung disease: A prospective small case series clinical study. International Journal of Rheumatic Diseases.
Crossref
Ippei Miyamoto, Tetsuo Shimizu, Ryo Kusahana, Masayuki Nomoto, Daishi Fujiwara, Tsukasa Nishizawa, Kentaro Hayashi, Yoshiko Nakagawa & Yasuhiro Gon. (2023) Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report. BMC Pulmonary Medicine 23:1.
Crossref
Haoran Chen, Huarui Liu, Wenting Lyu, Yin Liu, Mei Huang, Yingwei Zhang, Yuying Qiu, Yonglong Xiao, Hourong Cai & Jinghong Dai. (2022) An observational study of clinical recurrence in patients with interstitial lung disease related to the antisynthetase syndrome. Clinical Rheumatology 42:3, pages 711-720.
Crossref
Kai‐Fa Teo, Der‐Yuan Chen, Jeh‐Ting Hsu, Yi‐Hua Lai, Ching‐Kun Chang, Po‐Ren Hsueh, Joung‐Liang Lan & Jye‐Lin Hsu. (2022) Screening and characterization of myositis‐related autoantibodies in COVID ‐19 patients . Clinical and Translational Science 16:1, pages 140-150.
Crossref
Takuma Koga, Masaki Okamoto, Minoru Satoh, Kiminori Fujimoto, Yoshiaki Zaizen, Tomonori Chikasue, Akiko Sumi, Shinjiro Kaieda, Norikazu Matsuo, Goushi Matama, Takashi Nouno, Masaki Tominaga, Kazuhiro Yatera, Hiroaki Ida & Tomoaki Hoshino. (2022) Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias. Biomedicines 10:10, pages 2469.
Crossref
YUKI YORISHIMA, MASAKI TOMINAGA, KIMINORI FUJIMOTO, SHUJI NAGATA, AKIKO SUMI, TOMONORI CHIKASUE, MASAKI OKAMOTO, SHINJIRO KAIEDA, GOUSHI MATAMA, YOSHIAKI ZAIZEN, HITOSHI OBARA, TATSUYUKI KAKUMA, HIROAKI IDA, TOMOTAKA KAWAYAMA & TOMOAKI HOSHINO. (2022) Combination of Prednisolone and Calcineurin Inhibitors Prevents Lung Function Decline in Patients with Anti-aminoacyl-tRNA Synthetase Antibody-Positive Polymyositis/Dermatomyositis. The Kurume Medical Journal 69:1.2, pages 19-30.
Crossref
Fatima HaliluLisa Christopher-Stine. (2022) Myositis-specific antibodies: Overview and clinical utilization. Rheumatology and Immunology Research 3:1, pages 1-10.
Crossref
Pankti Mehta, Upendra Rathore, R. Naveen, Rudrarpan Chatterjee, Vikas Agarwal, Rohit Aggarwal & Latika Gupta. (2022) Prevalent Drug Usage Practices in Adults and Children With Idiopathic Inflammatory Myopathies. JCR: Journal of Clinical Rheumatology 28:2, pages 89-96.
Crossref
Paul Decker, Vincent Sobanski, Thomas Moulinet, David Launay, Eric Hachulla, Victor Valentin, Benoit Godbert, Sabine Revuz, Anne Guillaumot, Emmanuel Gomez, François Chabot, Lidwine Wémeau & Roland Jaussaud. (2022) Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up. European Journal of Internal Medicine 97, pages 62-68.
Crossref
Koichiro Shinoda, Maiko Okumura, Satoshi Yamaguchi, Atsushi Matsui, Reina Tsuda, Hiroyuki Hounoki, Shigeaki Suzuki & Kazuyuki Tobe. (2022) A Comparison of Line Blots, Enzyme-linked Immunosorbent, and RNA-immunoprecipitation Assays of Antisynthetase Antibodies in Serum Samples from 44 Patients. Internal Medicine 61:3, pages 313-322.
Crossref
Toshiya Hiramatsu, Moeko Murano, Shogo Nakai, Yurina Murakami, Koji Nishimoto, Sayomi Matsushima, Masanori Harada, Tomohiro Uto, Jun Sato, Shiro Imokawa & Takafumi Suda. (2022) Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies. Respiratory Medicine Case Reports 36, pages 101606.
Crossref
Xi Zhan, Wei Yan, Ying Wang, Qing Li, Xuhua Shi, Yanli Gao & Qiao Ye. (2021) Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. BMC Pulmonary Medicine 21:1.
Crossref
Yukihisa Takeda, Mariko Ono, Hayato Kinoshita, Yoko Nagatomo, Hiroki Miyauchi, Hiroshi Tsukamoto, Hiroyuki Nakamura & Kazutetsu Aoshiba. (2021) Acute respiratory distress syndrome relapsing in 10 months with an initial manifestation of polymyositis. Clinical Case Reports 9:12.
Crossref
Adelle S. Jee, Matthew J.S. Parker, Jane F. Bleasel, Lauren K. Troy, Edmund M. Lau, Helen E. Jo, Alan K.Y. Teoh, Susanne Webster, Stephen Adelstein & Tamera J. Corte. (2021) Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine 187, pages 106581.
Crossref
Ryoko Egashira. (2021) High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease. Medicina 57:7, pages 692.
Crossref
Yuko Waseda. (2021) Myositis-Related Interstitial Lung Disease: A Respiratory Physician’s Point of View. Medicina 57:6, pages 599.
Crossref
Reina Hara, Masaki Kanazu, Ami Iwai, Tomoki Kuge, Mikako Ishijima, Takeshi Uenami, Yuki Akazawa, Yukihiro Yano, Toshihiko Yamaguchi & Masahide Mori. (2021) EGFR ‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib . Thoracic Cancer 12:9, pages 1441-1444.
Crossref
Tomoyuki Fujisawa. (2021) Management of Myositis-Associated Interstitial Lung Disease. Medicina 57:4, pages 347.
Crossref
Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui & Takafumi Suda. (2020) Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD : A randomized, open‐label trial . Respirology 26:4, pages 370-377.
Crossref
Kiyoharu Fukushima, Takashi Satoh, Hiroshi Kida & Atsushi Kumanogoh. (2020) Revisiting Cell Death Responses in Fibrotic Lung Disease: Crosstalk between Structured and Non-Structured Cells. Diagnostics 10:7, pages 504.
Crossref
Kazuki M. Matsuda, Ayumi Yoshizaki, Ai Kuzumi, Takemichi Fukasawa, Satoshi Ebata, Asako Yoshizaki‐Ogawa & Shinichi Sato. (2020) Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis. The Journal of Dermatology 47:5, pages 483-489.
Crossref
Reoto Takei, Yasuhiko Yamano, Kensuke Kataoka, Toshiki Yokoyama, Toshiaki Matsuda, Tomoki Kimura, Takeshi Johkoh, Osamu Takahashi & Yasuhiro Kondoh. (2020) Predictive factors for the recurrence of anti-aminoacyl-tRNA synthetase antibody-associated interstitial lung disease. Respiratory Investigation 58:2, pages 83-90.
Crossref
Anna Masiak, Monika Marzec, Julia Kulczycka & Zbigniew Zdrojewski. (2020) The clinical phenotype associated with antisynthetase autoantibodies. Rheumatology 58:1, pages 4-8.
Crossref
Kiyoharu Fukushima, Kazuyuki Tsujino, Shinji Futami & Hiroshi Kida. (2020) Natural Autoantibodies in Chronic Pulmonary Diseases. International Journal of Molecular Sciences 21:3, pages 1138.
Crossref
Caterina Vacchi, Marco Sebastiani, Giulia Cassone, Stefania Cerri, Giovanni Della Casa, Carlo Salvarani & Andreina Manfredi. (2020) Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review. Journal of Clinical Medicine 9:2, pages 407.
Crossref
Kei Nagai, Masahiro Niisaka, Masayuki Nakajima, Yoshinori Sakata & Yoshiharu Nakamura. (2020) Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease. Journal of Rural Medicine 15:4, pages 225-229.
Crossref
Hiroyuki Kagawa, Kazuyuki Tsujino, Yuji Yamamoto, Ami Iwai, Reina Hara, Takanori Matsuki, Kiyoharu Fukushima, Yohei Oshitani, Kenji Yoshimura, Mari Miki, Keisuke Miki, Seigo Kitada, Masahide Mori & Hiroshi Kida. (2020) Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease:A case report. Respiratory Medicine Case Reports 29, pages 101016.
Crossref
Lei Jiang, Julia Jones & Xiang-Lei Yang. 2020. Biology of Aminoacyl-tRNA Synthetases. Biology of Aminoacyl-tRNA Synthetases 277 319 .
Vincent Cottin, Thomas Barba, Sabine Mainbourg, Mouhamad Nasser, Claudia Valenzuela & Jean-Christophe Lega. 2019. Pulmonary Manifestations of Systemic Diseases. Pulmonary Manifestations of Systemic Diseases 68 89 .
Xingguo Yang, Lei Yu, Fei Li, Tao Yu, Yunfeng Zhang & Honggang Liu. (2019) Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report. Thoracic Cancer 10:10, pages 2031-2034.
Crossref
Keiji Ohashi, Ken-Ei Sada, Yu Nakai, Shun Matsushima, Yosuke Asano, Keigo Hayashi, Yuriko Yamamura, Sumie Hiramatsu, Yoshia Miyawaki, Michiko Morishita, Takayuki Katsuyama, Eri Katsuyama, Haruki Watanabe, Noriko Tatebe, Mariko Narazaki, Yoshinori Matsumoto, Katsue Sunahori Watanabe, Tomoko Kawabata & Jun Wada. (2019) Cluster Analysis Using Anti–Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis. JCR: Journal of Clinical Rheumatology 25:6, pages 246-251.
Crossref
Yoshinari Nakatsuka, Tomohiro Handa, Ran Nakashima, Kiminobu Tanizawa, Takeshi Kubo, Yuko Murase, Akihiko Sokai, Kohei Ikezoe, Yuji Hosono, Kizuku Watanabe, Shinsaku Tokuda, Kazuko Uno, Akihiko Yoshizawa, Tatsuaki Tsuruyama, Ryuji Uozumi, Sonoko Nagai, Kazuhiro Hatta, Yoshio Taguchi, Michiaki Mishima, Kazuo Chin, Tsuneyo Mimori & Toyohiro Hirai. (2019) Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease. Rheumatology 58:8, pages 1465-1473.
Crossref
Satoshi Takanashi, Naoshi Nishina, Maho Nakazawa, Yuko Kaneko & Tsutomu Takeuchi. (2019) Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease. Rheumatology 58:6, pages 1034-1039.
Crossref
Hironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Naoki Inui, Yutaro Nakamura, Tsuneyo Mimori & Takafumi Suda. (2019) Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody–positive Polymyositis/dermatomyositis–associated Interstitial Lung Disease: A Propensity Score–matched Analysis. The Journal of Rheumatology 46:5, pages 509-517.
Crossref
Takao Fujii. (2019) 8. Clinical and Pathological Significances of Autoantibodies in Patients with Systemic Rheumatic Diseases8.膠原病における自己抗体の臨床的意義と病原性. Nihon Naika Gakkai Zasshi 108:3, pages 493-497.
Crossref
So-My Koo, Song Yee Kim, Sun Mi Choi & Hyun-Kyung Lee. (2019) Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease. Tuberculosis and Respiratory Diseases 82:4, pages 285.
Crossref
Kosaku Murakami & Tsuneyo Mimori. (2019) Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders. Internal Medicine 58:1, pages 5-14.
Crossref
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2018) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Neurology and Clinical Neuroscience 7:1, pages 3-21.
Crossref
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2019) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. The Journal of Dermatology 46:1, pages e1-e18.
Crossref
Olga Kryštůfková, Hana Hulejová, Heřman F. Mann, Ondřej Pecha, Ivana Půtová, Louise Ekholm, Ingrid E. Lundberg & Jiří Vencovský. (2018) Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis. Arthritis Research & Therapy 20:1.
Crossref
Kakuhiro Yamaguchi, Hiroshi Iwamoto, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Nobuoki Kohno & Noboru Hattori. (2018) Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody. Medicine 97:49, pages e13542.
Crossref
Go Saito, Masato Kono, Akari Tsutsumi, Yu Koyanagi, Koichi Miyashita, Takeshi Kobayashi, Hironao Hozumi, Yoshihiro Miki, Yoshifumi Arai, Yoshiro Otsuki, Dai Hashimoto, Tomoyuki Fujisawa, Toru Nakamura, Takafumi Suda & Hidenori Nakamura. (2018) Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion. Internal Medicine 57:15, pages 2227-2232.
Crossref
Tatsuya Kusumoto, Satoshi Okamori, Keita Masuzawa, Takanori Asakura, Naoshi Nishina, Shotaro Chubachi, Katsuhiko Naoki, Koichi Fukunaga & Tomoko Betsuyaku. (2018) Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody. Internal Medicine 57:14, pages 2045-2049.
Crossref
M. Best, M. Jachiet, N. Molinari, F. Manna, C. Girard, V. Pallure, A. Cosnes, D. Lipsker, T. Hubiche, J.-L. Schmutz, Y. Le Corre, N. Cordel, M. Dandurand, O. Dereure, B. Guillot, A. Du-Thanh, C. Bulai Livideanu, F. Chasset, J.-D. Bouaziz, C. Francès, D. Bengoufa, T. Vincent & D. Bessis. (2018) Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients. Journal of the European Academy of Dermatology and Venereology 32:7, pages 1164-1172.
Crossref
Kentaro Isoda, Takuya Kotani, Tohru Takeuchi, Junichi Konma, Takaaki Ishida, Kenichiro Hata, Kenichiro Otani, Hiroshi Fujiwara, Takeshi Shoda, Shigeki Makino & Shigeki Arawaka. (2018) Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis. The Clinical Respiratory Journal 12:7, pages 2235-2241.
Crossref
S. G. Gofrit, H. Yonath, M. Lidar, Y. Shoenfeld & S. Kivity. (2018) The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders. Clinical Rheumatology 37:5, pages 1257-1263.
Crossref
Kevin Didier, Loïs Bolko, Delphine Giusti, Segolene Toquet, Ailsa Robbins, Frank Antonicelli & Amelie Servettaz. (2018) Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?. Frontiers in Immunology 9.
Crossref
Maho Nakazawa, Yuko Kaneko & Tsutomu Takeuchi. (2017) Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study. Clinical Rheumatology 37:3, pages 765-771.
Crossref
Wakako Daido, Masahiro Yamasaki, Yuka Morio, Kunihiko Funaishi, Sayaka Ishiyama, Naoko Deguchi, Masaya Taniwaki, Nobuyuki Ohashi & Noboru Hattori. (2018) A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy. Internal Medicine 57:6, pages 849-853.
Crossref
K. E. N. Clark & D. A. Isenberg. (2018) A review of inflammatory idiopathic myopathy focusing on polymyositis. European Journal of Neurology 25:1, pages 13-23.
Crossref
Fernando Henrique Carlos de Souza. (2017) Autoanticorpos em miopatias autoimunes. Revista Paulista de Reumatologia:2017 out-dez;16(4), pages 12-16.
Crossref
Akira Takeda & Yoshiki Ishii. 2017. Contemporary Topics of Pneumonia. Contemporary Topics of Pneumonia.
Hirokazu Yura, Noriho Sakamoto, Minoru Satoh, Hiroshi Ishimoto, Tetsuya Hanaka, Chiyo Ito, Tomoko Hasegawa, Shin Tanaka, Takuto Miyamura, Shota Nakashima, Atsuko Hara, Tomoyuki Kakugawa, Keishi Oda, Takashi Kido, Yasushi Obase, Yuji Ishimatsu, Kazuhiro Yatera, Atsushi Kawakami & Hiroshi Mukae. (2017) Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia. Respiratory Medicine 132, pages 189-194.
Crossref
Reham Shindi, Amna Almehairi, Ola H. Negm, Noor Kalsheker, Nichola S. Gale, Dennis J. Shale, Timothy W. Harrison, Charlotte E. Bolton, Michelle John, Ian Todd, Patrick J. Tighe & Lucy C. Fairclough. (2017) Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease. Clinical Immunology 183, pages 344-353.
Crossref
Hironao Hozumi, Tomoyuki Fujisawa, Noriyuki Enomoto, Ran Nakashima, Yasunori Enomoto, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhashi, Akihiro Murakami, Naoki Inui, Yutaro Nakamura, Tsuneyo Mimori & Takafumi Suda. (2017) Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease. The Journal of Rheumatology 44:9, pages 1394-1401.
Crossref
Kentaro Isoda, Takuya Kotani, Tohru Takeuchi, Takao Kiboshi, Kenichiro Hata, Takaaki Ishida, Kenichiro Otani, Takao Kamimori, Hiroshi Fujiwara, Takeshi Shoda & Shigeki Makino. (2017) Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody. Rheumatology International 37:8, pages 1335-1340.
Crossref
Patrick M. Kwon, Lan Zhou, Rajeev Motiwala, Leslie D. KerrSusan C. Shin. (2017) Immune Myopathy With Perimysial Pathology Associated With Interstitial Lung Disease and Anti-EJ Antibodies. Journal of Clinical Neuromuscular Disease 18:4, pages 223-227.
Crossref
Kiminobu Tanizawa, Tomohiro Handa, Ran Nakashima, Takeshi Kubo, Yuji Hosono, Kizuku Watanabe, Kensaku Aihara, Kohei Ikezoe, Akihiko Sokai, Yoshinari Nakatsuka, Yoshio Taguchi, Kazuhiro Hatta, Satoshi Noma, Yoichiro Kobashi, Akihiko Yoshizawa, Toru Oga, Toyohiro Hirai, Kazuo Chin, Sonoko Nagai, Takateru Izumi, Tsuneyo Mimori & Michiaki Mishima. (2017) The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies. Respiratory Medicine 127, pages 57-64.
Crossref
Tomoyuki Fujisawa, Hironao Hozumi, Masato Kono, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Ran Nakashima, Yoshitaka Imura, Tsuneyo Mimori & Takafumi Suda. (2017) Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases. Respiratory Investigation 55:2, pages 130-137.
Crossref
Yoshimasa Hamano, Hiroshi Kida, Shoichi Ihara, Akihiro Murakami, Masahiro Yanagawa, Ken Ueda, Osamu Honda, Lokesh P. Tripathi, Toru Arai, Masaki Hirose, Toshimitsu Hamasaki, Yukihiro Yano, Tetsuya Kimura, Yasuhiro Kato, Hyota Takamatsu, Tomoyuki Otsuka, Toshiyuki Minami, Haruhiko Hirata, Koji Inoue, Izumi Nagatomo, Yoshito Takeda, Masahide Mori, Hiroyoshi Nishikawa, Kenji Mizuguchi, Takashi Kijima, Masanori Kitaichi, Noriyuki Tomiyama, Yoshikazu Inoue & Atsushi Kumanogoh. (2017) Classification of idiopathic interstitial pneumonias using anti–myxovirus resistance-protein 1 autoantibody. Scientific Reports 7:1.
Crossref
Naomi Yoshida, Masaki Okamoto, Shinjiro Kaieda, Kiminori Fujimoto, Tomohiro Ebata, Morihiro Tajiri, Masayuki Nakamura, Masaki Tominaga, Daisuke Wakasugi, Tomotaka Kawayama, Masataka Kuwana, Tsuneyo Mimori, Hiroaki Ida & Tomoaki Hoshino. (2017) Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease. Respiratory Investigation 55:1, pages 24-32.
Crossref
Hajime Sasano, Eri Hagiwara, Hideya Kitamura, Yasunori Enomoto, Norikazu Matsuo, Tomohisa Baba, Shinichiro Iso, Koji Okudela, Tae Iwasawa, Shinji Sato, Yasuo Suzuki, Tamiko Takemura & Takashi Ogura. (2016) Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulmonary Medicine 16:1.
Crossref
Hironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima, Takeshi Johkoh, Hiromitsu Sumikawa, Akihiro Murakami, Noriyuki Enomoto, Naoki Inui, Yutaro Nakamura, Yuji Hosono, Yoshitaka Imura, Tsuneyo Mimori & Takafumi Suda. (2016) Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease. Respiratory Medicine 121, pages 91-99.
Crossref
Y. Uzunhan, O. Freynet, B. Hervier, A. Guyot, M. Miyara & H. Nunes. (2016) Les manifestations respiratoires au cours des myopathies inflammatoires idiopathiquesPulmonary manifestations of idiopathic inflammatory myositis. Médecine Intensive Réanimation.
Crossref
R Nakashima, Y Hosono & T Mimori. (2016) Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25:8, pages 925-933.
Crossref
Z. Betteridge & N. McHugh. (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. Journal of Internal Medicine 280:1, pages 8-23.
Crossref
Vincent Cottin. (2015) Idiopathic interstitial pneumonias with connective tissue diseases features: A review. Respirology 21:2, pages 245-258.
Crossref
Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, Marcello Govoni, Francisco Javier Lopez Longo, Franco Franceschini, Rossella Neri, Santos Castañeda, Walter Alberto Sifuentes Giraldo, Roberto Caporali, Florenzo Iannone, Enrico Fusaro, Giuseppe Paolazzi, Raffaele Pellerito, Andreas Schwarting, Lesley Ann Saketkoo, Norberto Ortego-Centeno, Luca Quartuccio, Elena Bartoloni, Christof Specker, Trinitario Pina Murcia, Renato La Corte, Federica Furini, Valentina Foschi, Javier Bachiller Corral, Paolo Airò, Ilaria Cavazzana, Julia Martínez-Barrio, Michelle Hinojosa, Margherita Giannini, Simone Barsotti, Julia Menke, Kostantinos Triantafyllias, Rosetta Vitetta, Alessandra Russo, Gianluigi Bajocchi, Elena Bravi, Giovanni Barausse, Roberto Bortolotti, Carlo Selmi, Simone Parisi, Carlomaurizio Montecucco & Miguel Angel González-Gay. (2015) Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome. Medicine 94:32, pages e1144.
Crossref
Takahiro Oike, Tatsuya Ohno, Katsuyuki Shirai, Takashi Inoue & Takashi Nakano. (2015) Polymyositis and fatal interstitial pneumonia following pelvic irradiation that led to unexpectedly severe adverse effects: a case report. Clinical Case Reports 3:8, pages 710-713.
Crossref
Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu & Vincent Cottin. (2015) Idiopathic inflammatory myopathies and the lung. European Respiratory Review 24:136, pages 216-238.
Crossref
Shelly A. Miller, Marilyn K. Glassberg & Dana P. Ascherman. (2015) Pulmonary Complications of Inflammatory Myopathy. Rheumatic Disease Clinics of North America 41:2, pages 249-262.
Crossref
Hironao Hozumi, Noriyuki Enomoto, Masato Kono, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Hiromitsu Sumikawa, Takeshi Johkoh, Ran Nakashima, Yoshitaka Imura, Tsuneyo Mimori & Takafumi Suda. (2015) Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study. PLOS ONE 10:3, pages e0120313.
Crossref
Masaaki Matsushima, Yuka Shimizu, Ikuko Takahashi, Kazunori Sato, Makoto Hirotani, Takahiro Kano, Ichiro Yabe & Hidenao Sasaki. (2015) A case of anti-PL7 antibody positive myositis and a clinical and pathological review of the anti-synthetase syndrome. Rinsho Shinkeigaku 55:11, pages 810-815.
Crossref
Hajime Yoshifuji. (2016) Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S36748.
Crossref
Hidenaga KawasumiTakahisa GonoYasushi KawaguchiHisashi Yamanaka. (2015) Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23313.
Crossref
Hiroshi FurukawaShomi OkaKota ShimadaNaoyuki TsuchiyaShigeto Tohma. (2015) Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight) . Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23283.
Crossref
Jean-Christophe Lega, Nicole Fabien, Quitterie Reynaud, Isabelle Durieu, Stéphane Durupt, Marine Dutertre, Jean-François Cordier & Vincent Cottin. (2014) The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmunity Reviews 13:9, pages 883-891.
Crossref
Frank Schneider, Samuel A Yousem, David Bi, Kevin F Gibson, Chester V Oddis & Rohit Aggarwal. (2014) Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy. Journal of Clinical Pathology 67:8, pages 678-683.
Crossref
B. Hervier & O. Benveniste. (2014) Phénotypes cliniques et pronostic du syndrome des antisynthétases. La Revue de Médecine Interne 35:7, pages 453-460.
Crossref
T Yokoyama, T Fujii, S Kondo-Ishikawa, N Yamakawa, M Nakano, N Yukawa, H Yoshifuji, K Ohmura & T Mimori. (2014) Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus. Lupus 23:7, pages 635-642.
Crossref
Samuel A. Yousem, Frank Schneider, David Bi, Chester V. Oddis, Kevin Gibson & Rohit Aggarwal. (2014) The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome. Human Pathology 45:6, pages 1199-1204.
Crossref
Ran Nakashima, Yoshitaka Imura, Yuji Hosono, Minae Seto, Akihiro Murakami, Kizuku Watanabe, Tomohiro Handa, Michiaki Mishima, Michito Hirakata, Tsutomu Takeuchi, Keishi Fujio, Kazuhiko Yamamoto, Hitoshi Kohsaka, Yoshinari Takasaki, Noriyuki Enomoto, Takafumi Suda, Kingo Chida, Shu Hisata, Toshihiro Nukiwa & Tsuneyo Mimori. (2014) The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia. PLoS ONE 9:1, pages e85062.
Crossref
Takao Fujii. (2014) Direct and Indirect Pathogenic of Autoantibodies in Systemic Autoimmune Diseases. Allergology International 63:4, pages 515-522.
Crossref
Rohit Aggarwal, Elaine Cassidy, Noreen Fertig, Diane Carol Koontz, Mary Lucas, Dana P Ascherman & Chester V Oddis. (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Annals of the Rheumatic Diseases 73:1, pages 227-232.
Crossref
Steven D. Nathan. 2014. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis 221 238 .
B. Maurer. (2013) Frühsymptome der Dermatomyositis und des Antisynthetase-SyndromsEarly symptoms of dermatomyositis and antisynthetase syndrome. Zeitschrift für Rheumatologie 72:10, pages 970-976.
Crossref
J. Wang, G. Guo, G. Chen, B. Wu, L. Lu & L. Bao. (2013) Meta-analysis of the association of dermatomyositis and polymyositis with cancer. British Journal of Dermatology 169:4, pages 838-847.
Crossref
Patrick D. W. Kiely & Felix Chua. (2013) Interstitial Lung Disease in Inflammatory Myopathies: Clinical Phenotypes and Prognosis. Current Rheumatology Reports 15:9.
Crossref
Baptiste Hervier & Olivier Benveniste. (2013) Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome. Current Rheumatology Reports 15:8.
Crossref
Isabelle Marie, Séverine Josse, Olivier Decaux, Stéphane Dominique, Cédric Landron, Pascal Roblot, Stéphane Jouneau, Olivier Vittecoq & Fabienne Jouen. (2013) Outcome of anti-PL12 positive patients with antisynthetase syndrome. La Presse Médicale 42:6, pages e153-e158.
Crossref
I. Marie, S. Josse, P. Y. Hatron, S. Dominique, E. Hachulla, A. Janvresse, P. Cherin, L. Mouthon, O. Vittecoq, J.‐F. Menard & F. Jouen. (2013) Interstitial Lung Disease in Anti–Jo‐1 Patients With Antisynthetase Syndrome. Arthritis Care & Research 65:5, pages 800-808.
Crossref
Axel M. Gressner & Torsten Arndt. 2013. Lexikon der Medizinischen Laboratoriumsdiagnostik. Lexikon der Medizinischen Laboratoriumsdiagnostik 903 984 .
Baptiste Hervier, Hervé Devilliers, Raluca Stanciu, Alain Meyer, Yurdagul Uzunhan, Agathe Masseau, Sylvain Dubucquoi, Pierre-Yves Hatron, Lucile Musset, Benoit Wallaert, Hilario Nunes, Thierry Maisonobe, Nils-Olivier Olsson, Daniel Adoue, Philippe Arlet, Jean Sibilia, Marguerite Guiguet, Dominique Lauque, Zahir Amoura, Eric Hachulla, Mohamed Hamidou & Olivier Benveniste. (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmunity Reviews 12:2, pages 210-217.
Crossref
Lisa Christopher-Stine, Dwight R. Robinson, Carol C. Wu & Eugene J. Mark. (2012) Case 37-2012. New England Journal of Medicine 367:22, pages 2134-2146.
Crossref
I. Marie, S. Josse, O. Decaux, S. Dominique, E. Diot, C. Landron, P. Roblot, S. Jouneau, P.Y. Hatron, K.P. Tiev, O. Vittecoq, D. Noel, L. Mouthon, J.-F. Menard & F. Jouen. (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmunity Reviews 11:10, pages 739-745.
Crossref
T. Koga, K. Fujikawa, Y. Horai, A. Okada, S.-y. Kawashiri, N. Iwamoto, T. Suzuki, Y. Nakashima, M. Tamai, K. Arima, S. Yamasaki, H. Nakamura, T. Origuchi, Y. Hamaguchi, M. Fujimoto, Y. Ishimatsu, H. Mukae, M. Kuwana, S. Kohno, K. Eguchi, K. Aoyagi & A. Kawakami. (2012) The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology 51:7, pages 1278-1284.
Crossref
Isabelle Marie, Pierre Yves Hatron, Stéphane Dominique, Patrick Cherin, Luc Mouthon, Jean-François Menard, Hervé Levesque & Fabienne Jouen. (2012) Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody. Seminars in Arthritis and Rheumatism 41:6, pages 890-899.
Crossref
Hiromi Tomioka, Masahiro Kaneko, Yoshinori Kogata, Eiji Katsuyama, Seiko Ishikawa & Takao Fujii. (2012) A case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis. Respiratory Investigation 50:2, pages 66-69.
Crossref
Tsuneyo Mimori, Ran Nakashima & Yuji Hosono. (2012) Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment. Current Rheumatology Reports 14:3, pages 264-274.
Crossref
Manabu Fujimoto. (2012) Dermatomyositis: Myositis‐specific autoantibodies and skin manifestations. Clinical and Experimental Neuroimmunology 3:2, pages 74-84.
Crossref
Francesca Ingegnoli, Chiara Lubatti, Anna Ingegnoli, Patrizia Boracchi, Silvana Zeni & Pier Luigi Meroni. (2012) Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature. Autoimmunity Reviews 11:5, pages 335-340.
Crossref
C. Dieval, E. Ribeiro, P. Mercié, P. Blanco, P. Duffau & M. Longy-Boursier. (2012) Le syndrome des antisynthétases : étude rétrospective à propos d’une série de 14 patients. La Revue de Médecine Interne 33:2, pages 76-79.
Crossref
Madoka IIKAWA, MUROI Eiji, Yukichika ISHII, Kousuke MOCHIDA, Yujiro ODA, Mitsuru SETOYAMA, Shinichirou NARAHARA, Yasuhito HAMAGUCHI & Manabu FUJIMOTO. (2012) A Case of Anti-EJ Antibody-Positive Dermatomyositis with Severe Palpebral Edema. Nishi Nihon Hifuka 74:5, pages 488-492.
Crossref
Qusay Haydour, Melissa A. Wells, Sara S. McCoy, Eric Nelsen, Patricio Escalante & Eric L. Matteson. (2012) Anti-synthetase syndrome presenting as cryptogenic organizing pneumonia. Respiratory Medicine Case Reports 6, pages 13-15.
Crossref
Nobuaki IKEDA, Kazuo TAKAHASHI, Yukie YAMAGUCHI, Mai INASAKA, Masataka KUWANA & Zenro IKEZAWA. (2011) Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. The Journal of Dermatology 38:10, pages 973-979.
Crossref
Kizuku Watanabe, Tomohiro Handa, Kiminobu Tanizawa, Yuji Hosono, Yoshio Taguchi, Satoshi Noma, Yoichiro Kobashi, Takeshi Kubo, Kensaku Aihara, Kazuo Chin, Sonoko Nagai, Tsuneyo Mimori & Michiaki Mishima. (2011) Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respiratory Medicine 105:8, pages 1238-1247.
Crossref
David Fiorentino, Lorinda Chung, Jeff Zwerner, Antony Rosen & Livia Casciola-Rosen. (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. Journal of the American Academy of Dermatology 65:1, pages 25-34.
Crossref
Elena Katzap, Maria-Louise Barilla-LaBarca & Galina Marder. (2011) Antisynthetase Syndrome. Current Rheumatology Reports 13:3, pages 175-181.
Crossref
Joshua Solomon, Jeffrey J Swigris & Kevin K Brown. (2011) Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase. Jornal Brasileiro de Pneumologia 37:1, pages 100-109.
Crossref
Sonye K Danoff & Livia Casciola-Rosen. (2011) The lung as a possible target for the immune reaction in myositis. Arthritis Research & Therapy 13:4, pages 230.
Crossref
Zoe E Betteridge, Harsha Gunawardena & Neil J McHugh. (2011) Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Research & Therapy 13:2, pages 209.
Crossref
Paul F. Dellaripa & Ivan O. Rosas. 2011. Rheumatology. Rheumatology 315 320.e2 .
Miguel Mesa, Luis Fernando Pinto, Carlos Jaime Velásquez, Héctor Ortega & Javier Darío Márquez. (2010) Enfermedad pulmonar intersticial como manifestación inicial de síndrome antisintetasa. Revista Colombiana de Reumatología 17:4, pages 257-264.
Crossref
Takeshi Sato, Takao Fujii, Tomoko Yokoyama, Yoshimasa Fujita, Yoshitaka Imura, Naoichiro Yukawa, Daisuke Kawabata, Takaki Nojima, Koichiro Ohmura, Takashi Usui & Tsuneyo Mimori. (2010) Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis & Rheumatism 62:12, pages 3730-3740.
Crossref
Ran Nakashima & Tsuneyo Mimori. (2010) Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. International Journal of Clinical Rheumatology 5:5, pages 523-536.
Crossref
Samuel A Yousem, Kevin Gibson, Naftali Kaminski, Chester V Oddis & Dana P Ascherman. (2010) The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Modern Pathology 23:6, pages 874-880.
Crossref
B. Hervier, B. Wallaert, E. Hachulla, D. Adoue, D. Lauque, M. Audrain, B. Camara, B. Fournie, B. Couret, P. Y. Hatron, S. Dubucquoi & M. Hamidou. (2010) Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology 49:5, pages 972-976.
Crossref
Ran Nakashima, Yoshitaka Imura, Shio Kobayashi, Naoichiro Yukawa, Hajime Yoshifuji, Takaki Nojima, Daisuke Kawabata, Koichiro Ohmura, Takashi Usui, Takao Fujii, Katsuya Okawa & Tsuneyo Mimori. (2010) The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 49:3, pages 433-440.
Crossref
Yoshimizu Koreeda, Ikkou Higashimoto, Masuki Yamamoto, Mikiko Takahashi, Kenzo Kaji, Manabu Fujimoto, Masataka Kuwana & Yuh Fukuda. (2010) Clinical and Pathological Findings of Interstitial Lung Disease Patients with Anti-Aminoacyl-tRNA Synthetase Autoantibodies. Internal Medicine 49:5, pages 361-369.
Crossref
Andrew L. Mammen. (2010) Dermatomyositis and polymyositis. Annals of the New York Academy of Sciences 1184:1, pages 134-153.
Crossref
Isabel Bielsa Marsol. (2009) Dermatomiositis. Reumatología Clínica 5:5, pages 216-222.
Crossref
Thomas J. Richards, Aaron Eggebeen, Kevin Gibson, Samuel Yousem, Carl Fuhrman, Bernadette R. Gochuico, Noreen Fertig, Chester V. Oddis, Naftali Kaminski, Ivan O. Rosas & Dana P. Ascherman. (2009) Characterization and peripheral blood biomarker assessment of anti–Jo‐1 antibody–positive interstitial lung disease. Arthritis & Rheumatism 60:7, pages 2183-2192.
Crossref
Meena Kalluri, Steven A. Sahn, Chester V. Oddis, Suzanne L. Gharib, Lisa Christopher-Stine, Sonye K. Danoff, Livia Casciola-Rosen, Grace Hong, Paul F. Dellaripa & Kristin B. Highland. (2009) Clinical Profile of Anti-PL-12 Autoantibody. Chest 135:6, pages 1550-1556.
Crossref
H. Gunawardena, Z. E. Betteridge & N. J. McHugh. (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 48:6, pages 607-612.
Crossref
H. Gunawardena, L. R. Wedderburn, H. Chinoy, Z. E. Betteridge, J. North, W. E. R. Ollier, R. G. Cooper, C. V. Oddis, A. V. Ramanan, J. E. Davidson & N. J. McHugh. (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis & Rheumatism 60:6, pages 1807-1814.
Crossref
I. Bielsa. (2009) Nuevos autoanticuerpos en la dermatomiositis. Actas Dermo-Sifiliográficas 100:3, pages 182-189.
Crossref
Göran Tornling, Maryam Fathi & Ingrid E Lundberg. (2009) Pulmonary involvement in polymyositis and dermatomyositis. International Journal of Clinical Rheumatology 4:1, pages 45-56.
Crossref
Jan Gran, Øyvind Molberg, Gerd Dobloug, Helena Andersson, Eli Taraldsrud & David Scheie. (2009) Myosittspesifikke autoantistoffer. Tidsskrift for Den norske legeforening 129:16, pages 1631-1634.
Crossref
Kaori Okayasu, Yoshio Ohtani, Tamiko Takemura, Ken Uchibori, Meiyo Tamaoka, Masashi Furuiye, Yasunari Miyazaki, Naohiko Inase & Yasuyuki Yoshizawa. (2009) Nonspecific Interstitial Pneumonia (NSIP) Associated with Anti-KS Antibody: Differentiation from Idiopathic NSIP. Internal Medicine 48:15, pages 1301-1306.
Crossref
Isabel Bielsa Marsol. (2009) Dermatomyositis. Reumatología Clínica (English Edition) 5:5, pages 216-222.
Crossref
I. Bielsa. (2009) New Antibodies in Dermatomyositis. Actas Dermo-Sifiliográficas (English Edition) 100:3, pages 182-189.
Crossref
Galina S. Marder & Robert Greenwald. 2009. The Inflammatory Myopathies. The Inflammatory Myopathies 191 206 .
Ira N. Targoff. (2008) Autoantibodies and their significance in myositis. Current Rheumatology Reports 10:4, pages 333-340.
Crossref
. (2007) Current World Literature. Current Opinion in Rheumatology 19:6, pages 651-659.
Crossref
Tsuneyo Mimori, Yoshitaka Imura, Ran Nakashima & Hajime Yoshifuji. (2007) Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Current Opinion in Rheumatology 19:6, pages 523-529.
Crossref
Dong Soon Kim & Sonoko Nagai. (2007) Idiopathic Nonspecific Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine 176:7, pages 632-633.
Crossref
. (2007) Current World Literature. Current Opinion in Rheumatology 19:1, pages 81-89.
Crossref
Toshiya Hiramatsu, Moeko Murano, Shogo Nakai, Yurina Murakami, Koji Nishimoto, Sayomi Matsushima, Masanori Harada, Tomohiro Uto, Jun Sato, Shiro Imokawa & Takafumi Suda. (2021) Clinically Amyopathic Dermatomyositis with Interstitial Lung Disease Double-Positive for Anti-MDA5 and Anti-PL12 Antibodies. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.